ASU researchers named Senior Members of the National Academy of Inventors

Immunotherapy, Vaccines and Virotherapy

ASU researchers named Senior Members of the National Academy of Inventors

The National Academy of Inventors (NAI) has named Arizona State University Deputy Director Stephen Munk and professor Bertram Jacobs to the February 2022 class of Senior Members. This coveted distinction within NAI, an international organization, recognizes engineers,

From Here to Eternity: Astrocytes are harbors of long-term neurotropic infections

Join us for a seminar presented by Professor and Associate Chief Academic Officer at Fox Chase Cancer Center, Glenn F. Rall, Ph.D. This seminar is part of Viroholics, a weekly seminar series hosted by the Biodesign Center for Immunotherapy, Vaccines, and Virotherapy.

A biological paradox offers new insights into the mystery of cancer

The cells in the body can be thought of as tiny archery targets, each vulnerable to the deadly arrow of cancer.  The more cells a given animal has and the

OncoMyx Therapeutics, a privately-held immuno-oncology platform company,

OncoMyx closes $50 million series B to advance a novel immuno-oncology platform that delivers multiple cancer-killing payloads

PHOENIX, December 8, 2021 – OncoMyx Therapeutics, a company implementing Grant McFadden's research into cancer-killing oncolytic viruses, has just received $50M Series B funding to advance its work. McFadden directs

New review highlights cancer-crushing viruses

With the world still in the grip of a devastating pandemic, it’s hard to imagine viruses as something other than hostile enemies to be vanquished. But in a recent review article for the journal Cancers, Masmudur Rahman and Grant McFadden describe a class of viruses that act to combat rather than cause deadly disease. Such oncolytic viruses as they are known, have a remarkable ability to target and destroy cancer cells, while leaving healthy cells untouched. “The field of oncolytic

The innate immune responses during coronavirus infection

Henry (Yize) Li, PhD, Biodesign Center for Immunotherapy, Vaccines and Virotherapy Viroholics, will present as part of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy Viroholics Seminar Series. Join via Zoom: https://asu.zoom.us/j/88240683626.

Virus-Host interactions for Oncolytic Virotherapy

Masmudur Rahman, PhD, Biodesign Center for Immunotherapy, Vaccines and Virotherapy Viroholics, will present as part of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy Wednesday Seminar Series. Join via Zoom: https://asu.zoom.us/j/88567521236.

Reovirus replication factories: A tale of two machines

Terence S. Dermody, MD, University of Pittsburgh School of Medicine, will present as part of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy Viroholics Seminar Series. Join via Zoom: https://asu.zoom.us/j/88240683626.

Anaplasma phagocytophilum – Translating Microbial Pathogenesis Discoveries to Potential Protective and Therapeutic Approaches

Jason Carlyon, PhD, Virginia Commonwealth University School of Medicine, will present as part of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy Wednesday Seminar Series.

Co-operative signaling in double positive thymocytes

Fotini Gounari, PhD, University of Chicago, will present as part of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy Wednesday Seminar Series. Join via Zoom: https://asu.zoom.us/j/88567521236

Update on COVID-19 Vaccine-Induced Neutralizing Antibodies Using a Rapid Test

Doug Lake, PhD, Biodesign Virginia G. Piper Center for Personalized Diagnostics and Biodesign Center for Immunotherapy, Vaccines and Virotherapy, will present as part of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy Wednesday Seminar Series. Join via Zoom: https://asu.zoom.us/j/88567521236

High-throughput sequencing of SARS-CoV-2 in wastewater provides insights into circulating variants

Matthew Scotch, Ph.D., Biodesign Center for Environmental Health Engineering, will present as part of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy Wednesday Seminar Series.   Join via Zoom: https://asu.zoom.us/j/88567521236